Differential Effects of Newer-Generation Ultrathin-Strut Versus Thicker-Strut Drug-Eluting Stents in Chronic and Acute Coronary Syndromes
Open Access
- 1 November 2021
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 14 (22) , 2461-2473
Abstract
No abstract availableKeywords
Funding Information
- Abbott Vascular
- Medtronic
- Cardinal Health
- Edwards Lifesciences
- Biotronik
- Hôpitaux Universitaires de Genève
- AstraZeneca
- Université de Genève
- Boston Scientific Corporation
- Terumo
This publication has 35 references indexed in Scilit:
- Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in HumansCirculation, 2014
- Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary StentsCirculation, 2012
- Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantationThrombosis and Haemostasis, 2012
- Role of Endothelial Shear Stress in Stent Restenosis and ThrombosisJACC, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug CoatingsCirculation, 2011
- A basic introduction to fixed-effect and random-effects models for meta-analysisResearch Synthesis Methods, 2010
- Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificityEuroIntervention, 2010
- Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction PatientsCirculation, 2008
- Measuring inconsistency in meta-analysesBMJ, 2003